MDVZX
Price
$8.18
Change
+$0.06 (+0.74%)
Updated
Dec 24 closing price
RMEBX
Price
$55.73
Change
+$0.45 (+0.81%)
Updated
Dec 24 closing price
Ad is loading...

MDVZX vs RMEBX

Header iconMDVZX vs RMEBX Comparison
Open Charts MDVZX vs RMEBXBanner chart's image
Manning & Napier Disciplined Value Z
Price$8.18
Change+$0.06 (+0.74%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R2E
Price$55.73
Change+$0.45 (+0.81%)
VolumeN/A
CapitalizationN/A
MDVZX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDVZX vs. RMEBX commentary
Dec 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDVZX is a Buy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 103B vs. MDVZX (179M). MDVZX pays higher dividends than RMEBX: MDVZX (2.92) vs RMEBX (1.54). MDVZX was incepted earlier than RMEBX: MDVZX (6 years) vs RMEBX (10 years). MDVZX is a more actively managed with annual turnover of: 35.00 vs. RMEBX (25.00). RMEBX has a lower initial minimum investment than MDVZX: RMEBX (250) vs MDVZX (1000000). RMEBX annual gain was more profitable for investors over the last year : 11.90 vs. MDVZX (4.53). RMEBX return over 5 years is better than : 38.18 vs. MDVZX (10.96).
MDVZXRMEBXMDVZX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years10 years-
Gain YTD4.14311.15337%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets179M103B0%
Annual Yield % from dividends2.921.54189%
Returns for 1 year4.5311.9038%
Returns for 3 years-4.8311.77-41%
Returns for 5 years10.9638.1829%
Returns for 10 yearsN/A58.99-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRNS0.260.02
+8.07%
Marinus Pharmaceuticals
EXPD111.190.69
+0.62%
Expeditors International of Washington
PRTA15.400.07
+0.46%
Prothena Corp
FATE1.66N/A
N/A
Fate Therapeutics
RNG36.99-0.36
-0.96%
RINGCENTRAL